MR SPECTROSCOPY & VOXEL-BASED MORPHOMETRY OF THE CEREBELLUM IN LONG-TERM
先生光谱
基本信息
- 批准号:7603953
- 负责人:
- 金额:$ 0.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-01 至 2007-11-30
- 项目状态:已结题
- 来源:
- 关键词:AgeAtaxiaAtrophicAutoimmune ProcessBehavioralBrain regionCerebellumChildCognitiveComputer Retrieval of Information on Scientific Projects DatabaseConditionDevelopmentExcisionFundingGrantImmunosuppressive AgentsInstitutionMagnetic Resonance SpectroscopyModalityMotorNeuroblastomaNeurologicOpsoclonusOutcomeParaneoplastic Opsoclonus AtaxiaPharmaceutical PreparationsProblem behaviorResearchResearch PersonnelResourcesSourceSpectrum AnalysisStagingTechniquesTissuesUnited States National Institutes of Healthbaseimage processingmorphometryneuroimagingneuron losstumor
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Introduction: Opsoclonus-ataxia (OA) is a paraneoplastic, presumably autoimmune manifestation of occult neuroblastoma in young children. Typical age at presentation is 1-3 years, and the typical tumor is a small, somewhat differentiated, stage I or II neuroblastoma, without n-MYC amplification. Tumor removal does not alter the neurological condition. Treatment consists of immunosuppressive medication, which often is necessary for several years. Outcome is not optimal: most children who have had OA have substantial developmental and behavioral problems. Despite ongoing motor, cognitive and behavioral sequelae, typical neuroimaging of children who have had paraneoplastic OA is normal.
We propose use of newer neuroimaging modalities to look for subtle loss of tissue bulk or neuronal loss in the cerebellum
Specific Aim 1: To compare children who have had OA with normal children using a new image processing technique, voxel based morphometry, with particular emphasis on cerebellar volume.
Specific Aim 2: To compare children who have had OA with normal children using MR spectroscopy, with emphasis on the cerebellum, to assess for subtle neuronal loss without "atrophy". MRS from cerebellum will be compared to other brain regions as well as to normal comparison subjects.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
前言:眼阵挛共济失调(OA)是一种副肿瘤,可能是自身免疫性表现的隐匿性神经母细胞瘤在幼儿。典型的发病年龄是1-3岁,典型的肿瘤是一个小的,有些分化的,I或II期神经母细胞瘤,没有n-MYC扩增。肿瘤切除不会改变神经系统状况。治疗包括免疫抑制药物,这往往是必要的几年。结果并不理想:大多数患有OA的儿童都有严重的发育和行为问题。尽管存在运动、认知和行为后遗症,但患有副肿瘤性OA的儿童的典型神经影像学表现正常。
我们建议使用新的神经影像学方法来寻找小脑组织块或神经元丢失的细微损失
具体目标1:使用一种新的图像处理技术,基于体素的形态测量,特别强调小脑体积,将患有OA的儿童与正常儿童进行比较。
具体目标二:使用磁共振波谱分析比较患有OA的儿童与正常儿童,重点是小脑,以评估无“萎缩”的轻微神经元丢失。将来自小脑的MRS与其他脑区域以及正常比较受试者进行比较。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WENDY G. MITCHELL其他文献
WENDY G. MITCHELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WENDY G. MITCHELL', 18)}}的其他基金
MR SPECTROSCOPY & VOXEL-BASED MORPHOMETRY OF THE CEREBELLUM IN LONG-TERM
先生光谱
- 批准号:
7716728 - 财政年份:2008
- 资助金额:
$ 0.68万 - 项目类别:
MR SPECTROSCOPY & VOXEL-BASED MORPHOMETRY OF THE CEREBELLUM IN LONG-TERM
先生光谱
- 批准号:
7368235 - 财政年份:2005
- 资助金额:
$ 0.68万 - 项目类别:
MR SPECTROSCOPY & VOXEL-BASED MORPHOMETRY OF THE CEREBELLUM IN LONG-TERM
先生光谱
- 批准号:
7200043 - 财政年份:2004
- 资助金额:
$ 0.68万 - 项目类别:
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS
婴儿痉挛症患者氨己烯酸的临床经验和使用
- 批准号:
6421183 - 财政年份:2000
- 资助金额:
$ 0.68万 - 项目类别:
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS
婴儿痉挛症患者氨己烯酸的临床经验和使用
- 批准号:
6303705 - 财政年份:1999
- 资助金额:
$ 0.68万 - 项目类别:
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS
婴儿痉挛症患者氨己烯酸的临床经验和使用
- 批准号:
6113653 - 财政年份:1998
- 资助金额:
$ 0.68万 - 项目类别:
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS
婴儿痉挛症患者氨己烯酸的临床经验和使用
- 批准号:
6244814 - 财政年份:1997
- 资助金额:
$ 0.68万 - 项目类别:
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS
婴儿痉挛症患者氨己烯酸的临床经验和使用
- 批准号:
6274887 - 财政年份:1997
- 资助金额:
$ 0.68万 - 项目类别:
相似海外基金
How exercise improves ataxia in SCA6
运动如何改善 SCA6 的共济失调
- 批准号:
479005 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:
Operating Grants
Exploratoin of Nrf2 activators that potentiate chaperone-mediated autophagy and are useful for the treatment of spinocrebellar ataxia
探索增强伴侣介导的自噬并可用于治疗脊髓小脑共济失调的 Nrf2 激活剂
- 批准号:
23K06161 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
- 批准号:
10799992 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
- 批准号:
10607414 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
- 批准号:
10753403 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
- 批准号:
10668768 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
- 批准号:
10579736 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:
The Impact of Vitamin D on mTOR Signaling, Seizures, and Motor Behavior in a Mouse Model of Hyperactive mTOR Induced Epilepsy and Ataxia
维生素 D 对 mTOR 过度活跃诱发癫痫和共济失调小鼠模型中 mTOR 信号传导、癫痫发作和运动行为的影响
- 批准号:
10754319 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
- 批准号:
10740682 - 财政年份:2023
- 资助金额:
$ 0.68万 - 项目类别:














{{item.name}}会员




